Cooperative research continues
12 March, 2013 by Susan WilliamsonThe 15th selection round for cooperative research centres will see the government spend $70 million on three new centres.
Pharmaxis completes Bronchitol trial
11 March, 2013 by Dylan Bushell-EmblingPharmaxis (ASX:PXS) shares climbed 15% after the company revealed it had completed a phase III trial of Bronchitol in patients with bronchiectasis.
Signal strength
18 February, 2013 by Fiona WylieAssociate Professor Brendan Jenkins is helping to uncover the cellular signals involved in stomach cancer, which may one day be used as biomarkers or as new targets for treatment.
Deadly hantavirus jumps between species
14 February, 2013 by Signe CaneA study has found the potentially lethal hantavirus may have originated in bats and has subsequently jumped between species, raising important issues for pandemic prevention.
New insight into the catch-22 of obesity and dieting
06 February, 2013 by Signe CaneAustralian researchers have unravelled a longstanding mystery of obesity: why is it sometimes counterproductive for obese people to diet?
Vivid insight
04 February, 2013 by Tim DeanProfessor Paul Martin has his eye on uncovering the complexities of primate colour vision.
The campaigner
01 February, 2013 by Tim DeanFollowing a 30-year stint heading up the Walter and Eliza Hall Institute, Sir Gustav Nossal is now a top level advisor helping to advance the cause of global health. Here he reflects on his long and fruitful career.
Victorian Infection and Immunity Network gets $300K injection from Vic government
30 January, 2013 by Tim DeanA collaborative network of researchers in infection and immunity has received a $300,000 grant from the Victorian government to encourage industry partnerships.
Mesoblast to head to phase III for stem cell treatment for spinal fusion
11 January, 2013 by Tim DeanPositive phase II results for Mesoblast’s (ASX:MSB) stem cell treatment for spinal fusion have prompted the company to look at moving to phase III this year.
Mesoblast MPCs used to boost blood cell transplants
13 December, 2012 by Dylan Bushell-EmblingScientists from Mesoblast (ASX:MSB) and the University of Texas have been trialling a method for using Mesoblast's adult stem cells to accelerate the body's adoption of umbilical cord blood stem cell transplants.
Product release: Malvern Zetasizer ZSP
27 November, 2012 by Staff WritersThe new Zetasizer Nano ZSP is designed for the measurement of size, mobility of proteins, zeta potential of nanoparticles and surfaces and microrheology of protein or polymer solutions.
Feature: Wired to think
12 November, 2012 by Graeme O'NeillAustralian neuroscientist Professor Seth Grant, FRS, is transforming neuroscience by revealing the startling complexity of the synaptic proteome.
Comment: How we developed the Hendra virus vaccine for horses
02 November, 2012 by Staff WritersDeborah Middleton, Senior Veterinary Pathologist at CSIRO, explains how she and her team developed the groundbreaking vaccine for the deadly Hendra virus.
Stem cell pioneers receive Nobel Prize
09 October, 2012 by Tim DeanTwo pioneers of stem cell science have received the Nobel Prize in Physiology or Medicine "for the discovery that mature cells can be reprogrammed to become pluripotent".
Iron ‘blueberries’ may be sign of microbial life on Mars
13 September, 2012 by Tim DeanIt’s unlikely anything lives on Mars today, but it may well have done so millions or billions of years past. And it may have left traces of its existence in the geology of the red planet. One such tantalising hint was discovered by the NASA Opportunity Rover, which found small spherical hematite balls, dubbed ‘blueberries,’ in the Martian soil.
